pre-miRNA Information
pre-miRNA hsa-mir-637   
Genomic Coordinates chr19: 3961414 - 3961512
Synonyms MIRN637, hsa-mir-637, MIR637
Description Homo sapiens miR-637 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-637
Sequence 61| ACUGGGGGCUUUCGGGCUCUGCGU |84
Evidence Experimental
Experiments SAGE
Expression Profile
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN518997 2 COSMIC
COSN1082357 6 COSMIC
COSN13804010 13 COSMIC
COSN1082358 14 COSMIC
COSN30450169 14 COSMIC
COSN30532059 15 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1416171403 2 dbSNP
rs200224173 4 dbSNP
rs1475121792 9 dbSNP
rs202144891 13 dbSNP
rs767027646 14 dbSNP
rs529226642 16 dbSNP
rs751534327 17 dbSNP
rs758718359 17 dbSNP
rs149472696 20 dbSNP
rs773105166 21 dbSNP
rs543903246 22 dbSNP
rs374248027 24 dbSNP
Putative Targets

Gene Information
Gene Symbol CLSTN1   
Synonyms ALC-ALPHA, CDHR12, CST-1, CSTN1, PIK3CD, XB31alpha, alcalpha1, alcalpha2
Description calsyntenin 1
Transcript NM_001009566   
Other Transcripts NM_014944   
Expression
Putative miRNA Targets on CLSTN1
3'UTR of CLSTN1
(miRNA target sites are highlighted)
>CLSTN1|NM_001009566|3'UTR
   1 CCCGTGCCCCCGGCCACCTCGGTTTCTGCTTTCGAAGACTCTGCTGCCATCCGTTCTCCCAGTCCCAAGGGTCCACGATG
  81 TACAAAGTCATTTCGGCCAGTAGGTGTGCAGACCCCTCCCCGCCACGATCGTCGCTGTGCTTGGTGTGTAGGACCCTAGG
 161 CTCCCCGCCCACCCTCTGCCTGGTCGCGCTCTTCAGTCCCACGAGGAGCTGACACGTCCTCTCTGGCCGCCATCCGGCTC
 241 GCACAGGGGCCTCCCAGCGCCTCAGGCCCCGCGTTTGTGTCTGGAGTCTCCCCCCGGGGAGAGGACACTGGCCCCTCGCA
 321 CTCCAGAAAAGCCATGCCAGCTGGGCTCGTTGACAAAGGGTAAAACATGCTCACTCCCACCCGGTAATCATTTTTTTCTT
 401 TTTTTAAAAAAAGTTTTTATTTTTTCCAAACTAGTGCATGTATAAATAATGGCAGGATGGGGGGTACTGTGTAGATGATT
 481 AACTGACTTTTTAATATTTTGTAAATAAATCGGATTCCTTGTGTCCTTTGTGCTAGTGTAACCCGGGACTGGAATGTAAA
 561 GTGAAGTTCGGAGCTCTGAGCACGGGCTCTTCCCGCCGGGTCCTCCCTCCCCAGACCCCAGAGGGAGAGGCCCACCCCGC
 641 CCAGCCCCGCCCCAGCCCCTGCTCAGGTCTGAGTATGGCTGGGAGTCGGGGGCCACAGGCCTCTAGCTGTGCTGCTCAAG
 721 AGACTGGATCAGGGTAGCTACAAGTGGCCGGGCCTTGCCTTTGGGATTCTACCTGTTCCTAATTTGGTGTGGGGTGCGGG
 801 GTCCCTGGCCCCTTTTCCACACTCCTCCTCCGACAGCAGCTCCCTGGGCAGTGGCCTGGTCTCACCGTGTGCAGCCTTGT
 881 GGTTTATGCTTAAATGTACATTTTCCTGCTGGTAAAAGGAGAAACTGAGAGGTGTCCTGCAGACCGGCTGACCACTCCTT
 961 TTGGAGACGGCAGGAGGCCTGAGCGATCCGTACTCAGAACGTCCAGGAGAGACGCATGGCCCGAAGTCAAAGTGCTGGAA
1041 TTTTCCAAAACAGCCTGTTCTCTCCTCTCTCCTCCCCAGAGCACCCCCTGCCATCAGGGGGGTTGAAATCCCTCTCCCCC
1121 AGGAGCCCTGCTGCTTTGCTTGGTGGTAGGGCAGGAGAGCAAACAAACAGTCATGGTCTAAAACCCACATAGCACTTTGC
1201 TCTTAGTTACATGTAAAATTTTAGATTTCTAAAACAGGTGGGCAATCATTTTGAATACTGTTCTGTGACCCTGACTGCTA
1281 GTTCTGAGGACACTGGTGGCTGTGCTATGTGTGGCCATCCTCCATGTCCCGTCCCTGTAGCTGCTCTGTTTAGACAGCGG
1361 ACAGACGCTCACGCCCAGGGGATGTCCTCACGCTGTCGCCGCGCGGTTTCCCTTCGCAGATGTGTATACTCATGATAGGT
1441 CAGAAAGTGTATCCGCTACAATAAAGTTCTGGTTCTAACTAACTCCAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ugcgUCUCGGGCUUU------CGGGGGUCa 5'
              :|:| ::||||       ||||||| 
Target 5' tcagGGGGGTTGAAATCCCTCTCCCCCAGg 3'
1094 - 1123 150.00 -23.90
2
miRNA  3' ugcGUCUCGGGCUUUCGGGGGUCa 5'
             |:|:| ||  |:|||:|:|| 
Target 5' agtCGGGGGCCACAGGCCTCTAGc 3'
684 - 707 137.00 -24.70
3
miRNA  3' ugcgucucGGGCUUUCGGGGGUCa 5'
                  ||||   ||||||:| 
Target 5' --------CCCG--TGCCCCCGGc 3'
1 - 14 136.00 -23.70
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN26971042 3 COSMIC
COSN26971043 4 COSMIC
COSN26971035 11 COSMIC
COSN13569106 33 COSMIC
COSN31489765 43 COSMIC
COSN31598679 47 COSMIC
COSN30162667 76 COSMIC
COSN507647 77 COSMIC
COSN30108966 83 COSMIC
COSN26971037 112 COSMIC
COSN30103014 117 COSMIC
COSN30454675 120 COSMIC
COSN31498821 144 COSMIC
COSN26677991 170 COSMIC
COSN6954036 256 COSMIC
COSN17182975 271 COSMIC
COSN31531783 272 COSMIC
COSN30176067 919 COSMIC
COSN31534906 1019 COSMIC
COSN20806246 1569 COSMIC
rs14271 1416 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1319059059 1 dbSNP
rs759672760 2 dbSNP
rs200668377 3 dbSNP
rs771099481 4 dbSNP
rs760905356 6 dbSNP
rs1177881293 7 dbSNP
rs773956382 11 dbSNP
rs201581912 12 dbSNP
rs1451472788 13 dbSNP
rs1246279628 15 dbSNP
rs373087974 20 dbSNP
rs556240045 21 dbSNP
rs1256346474 22 dbSNP
rs1212021542 29 dbSNP
rs769162588 33 dbSNP
rs745409451 34 dbSNP
rs1245950489 35 dbSNP
rs532822000 43 dbSNP
rs780882170 43 dbSNP
rs756922857 48 dbSNP
rs963092144 50 dbSNP
rs1033955357 52 dbSNP
rs1002842741 53 dbSNP
rs537961353 58 dbSNP
rs1377745901 60 dbSNP
rs567410594 63 dbSNP
rs1439055393 64 dbSNP
rs1390258190 66 dbSNP
rs1163664307 68 dbSNP
rs1459270852 70 dbSNP
rs117948097 76 dbSNP
rs1003832329 78 dbSNP
rs1381693798 80 dbSNP
rs951279470 82 dbSNP
rs1294750674 87 dbSNP
rs1267647793 89 dbSNP
rs927398463 90 dbSNP
rs1211212534 93 dbSNP
rs1029582642 94 dbSNP
rs536015130 95 dbSNP
rs1050789515 100 dbSNP
rs997996836 103 dbSNP
rs899639754 104 dbSNP
rs1332087329 110 dbSNP
rs879052818 112 dbSNP
rs1382599224 116 dbSNP
rs1297345496 117 dbSNP
rs968670727 117 dbSNP
rs1389092190 118 dbSNP
rs1382064099 120 dbSNP
rs899655590 121 dbSNP
rs1018061123 122 dbSNP
rs935882467 123 dbSNP
rs1200549701 124 dbSNP
rs565867890 126 dbSNP
rs1216315230 127 dbSNP
rs181812755 130 dbSNP
rs1041392917 131 dbSNP
rs945666148 134 dbSNP
rs1344408936 145 dbSNP
rs892762319 155 dbSNP
rs1235778796 163 dbSNP
rs1056626604 166 dbSNP
rs532276918 167 dbSNP
rs981051890 168 dbSNP
rs77950539 170 dbSNP
rs1332129330 172 dbSNP
rs754307668 178 dbSNP
rs778142871 179 dbSNP
rs1460194913 184 dbSNP
rs549502337 186 dbSNP
rs1291518359 187 dbSNP
rs941462059 188 dbSNP
rs1265713124 191 dbSNP
rs909917841 194 dbSNP
rs1354997429 195 dbSNP
rs1281985066 202 dbSNP
rs1279488893 203 dbSNP
rs531480065 203 dbSNP
rs982841968 206 dbSNP
rs60073554 209 dbSNP
rs951353210 212 dbSNP
rs1365771023 215 dbSNP
rs899673144 216 dbSNP
rs1342144802 227 dbSNP
rs1029613957 228 dbSNP
rs149772081 229 dbSNP
rs1340968088 231 dbSNP
rs1000028076 235 dbSNP
rs1463632777 236 dbSNP
rs767817575 240 dbSNP
rs543279645 241 dbSNP
rs1041642088 242 dbSNP
rs1390103094 243 dbSNP
rs1161595437 244 dbSNP
rs1000403944 258 dbSNP
rs892445649 259 dbSNP
rs1472783697 261 dbSNP
rs1188510416 270 dbSNP
rs904276605 271 dbSNP
rs527906257 272 dbSNP
rs1199575331 273 dbSNP
rs1199122911 277 dbSNP
rs560454527 279 dbSNP
rs78105956 288 dbSNP
rs926726389 290 dbSNP
rs1287313884 291 dbSNP
rs981383132 292 dbSNP
rs941525967 295 dbSNP
rs1342298384 296 dbSNP
rs1448598670 296 dbSNP
rs895466499 300 dbSNP
rs113794825 314 dbSNP
rs982971412 315 dbSNP
rs556558334 317 dbSNP
rs1166019826 324 dbSNP
rs1438372901 333 dbSNP
rs1226158495 336 dbSNP
rs112497092 348 dbSNP
rs771174027 349 dbSNP
rs544194852 352 dbSNP
rs905418750 354 dbSNP
rs1451978692 355 dbSNP
rs1291756081 357 dbSNP
rs1237941615 358 dbSNP
rs1352871704 360 dbSNP
rs1309404993 367 dbSNP
rs188784317 369 dbSNP
rs1437440337 374 dbSNP
rs1273897764 377 dbSNP
rs749345073 382 dbSNP
rs1350894972 386 dbSNP
rs1305323294 391 dbSNP
rs1418457734 395 dbSNP
rs111708156 398 dbSNP
rs1360412516 398 dbSNP
rs77314922 399 dbSNP
rs1159736063 400 dbSNP
rs1420980328 404 dbSNP
rs1045237652 405 dbSNP
rs1029249482 406 dbSNP
rs964172066 413 dbSNP
rs976531595 413 dbSNP
rs1018013028 426 dbSNP
rs1330684721 426 dbSNP
rs1321863345 429 dbSNP
rs1248621182 434 dbSNP
rs1431651978 439 dbSNP
rs1371295959 445 dbSNP
rs1286683235 448 dbSNP
rs1168471788 451 dbSNP
rs1000464626 453 dbSNP
rs1309942191 458 dbSNP
rs904337391 465 dbSNP
rs914837423 465 dbSNP
rs573822405 468 dbSNP
rs1285625799 469 dbSNP
rs1398572479 480 dbSNP
rs118038247 481 dbSNP
rs910001624 484 dbSNP
rs1477910476 494 dbSNP
rs1244585528 501 dbSNP
rs1357558908 505 dbSNP
rs892476097 510 dbSNP
rs533993983 511 dbSNP
rs1431762833 512 dbSNP
rs1191720114 521 dbSNP
rs1477382161 522 dbSNP
rs1263553556 523 dbSNP
rs1188275584 525 dbSNP
rs1047578086 526 dbSNP
rs1483086376 533 dbSNP
rs905304782 537 dbSNP
rs1045137426 540 dbSNP
rs1250483062 544 dbSNP
rs1202934447 545 dbSNP
rs1313939779 546 dbSNP
rs941545702 566 dbSNP
rs565887940 569 dbSNP
rs773279202 570 dbSNP
rs910024058 583 dbSNP
rs1168806060 584 dbSNP
rs553638515 584 dbSNP
rs541310463 589 dbSNP
rs746894122 594 dbSNP
rs28492734 595 dbSNP
rs184347342 597 dbSNP
rs1351175834 599 dbSNP
rs1307557784 603 dbSNP
rs968952002 603 dbSNP
rs978507564 606 dbSNP
rs1318140567 611 dbSNP
rs1252298693 612 dbSNP
rs1230117927 613 dbSNP
rs989037332 615 dbSNP
rs1020053809 616 dbSNP
rs1009957369 617 dbSNP
rs1320242509 629 dbSNP
rs968549983 631 dbSNP
rs1312656327 632 dbSNP
rs956296730 634 dbSNP
rs549830821 638 dbSNP
rs1035325125 639 dbSNP
rs959980204 643 dbSNP
rs1177469563 644 dbSNP
rs1414218163 648 dbSNP
rs531318883 649 dbSNP
rs1035599605 652 dbSNP
rs562505473 653 dbSNP
rs1165400857 656 dbSNP
rs1423572930 660 dbSNP
rs1446366540 660 dbSNP
rs1177435382 661 dbSNP
rs1001116316 666 dbSNP
rs1003978298 673 dbSNP
rs1472753194 674 dbSNP
rs7526958 675 dbSNP
rs1045569502 687 dbSNP
rs1045716795 688 dbSNP
rs1005748464 689 dbSNP
rs888616133 691 dbSNP
rs888594411 692 dbSNP
rs1237934223 693 dbSNP
rs1047239504 695 dbSNP
rs549123589 703 dbSNP
rs930058876 707 dbSNP
rs930134539 714 dbSNP
rs1309438131 717 dbSNP
rs922648174 718 dbSNP
rs527351791 722 dbSNP
rs942667433 724 dbSNP
rs910855923 727 dbSNP
rs1269855867 732 dbSNP
rs1358583640 733 dbSNP
rs978922789 736 dbSNP
rs911177786 737 dbSNP
rs1364958855 740 dbSNP
rs1330018640 741 dbSNP
rs560749082 744 dbSNP
rs968637691 746 dbSNP
rs758099177 749 dbSNP
rs371817370 750 dbSNP
rs912980570 758 dbSNP
rs913077250 763 dbSNP
rs1284528705 769 dbSNP
rs988566807 770 dbSNP
rs1303915297 778 dbSNP
rs1351498042 779 dbSNP
rs988672219 785 dbSNP
rs959791021 794 dbSNP
rs1035395182 797 dbSNP
rs1330711966 797 dbSNP
rs1001196341 798 dbSNP
rs1338080087 800 dbSNP
rs1297513663 811 dbSNP
rs1036036268 813 dbSNP
rs758310156 818 dbSNP
rs1170278201 823 dbSNP
rs1023918168 824 dbSNP
rs1465266346 826 dbSNP
rs1377871220 827 dbSNP
rs969801214 831 dbSNP
rs1006229899 832 dbSNP
rs752835523 832 dbSNP
rs1448067856 835 dbSNP
rs888680158 837 dbSNP
rs1023595828 843 dbSNP
rs1323040752 847 dbSNP
rs1025819732 851 dbSNP
rs994301816 856 dbSNP
rs749883230 861 dbSNP
rs545265885 866 dbSNP
rs745670146 867 dbSNP
rs888565458 871 dbSNP
rs901289401 882 dbSNP
rs1410683906 886 dbSNP
rs1041145708 892 dbSNP
rs764754023 901 dbSNP
rs1156533909 908 dbSNP
rs1425018429 912 dbSNP
rs1047120560 924 dbSNP
rs942738362 926 dbSNP
rs994317461 927 dbSNP
rs901315810 928 dbSNP
rs1041702954 930 dbSNP
rs1422001050 931 dbSNP
rs1170381337 934 dbSNP
rs533725338 941 dbSNP
rs1475923289 942 dbSNP
rs1043040809 945 dbSNP
rs1471801361 946 dbSNP
rs1249830444 952 dbSNP
rs761669637 954 dbSNP
rs1205881811 955 dbSNP
rs913115474 968 dbSNP
rs988640375 969 dbSNP
rs1267694361 977 dbSNP
rs938516333 984 dbSNP
rs563016082 985 dbSNP
rs1282366126 987 dbSNP
rs41280774 989 dbSNP
rs1228241069 990 dbSNP
rs1381153551 992 dbSNP
rs1300452329 995 dbSNP
rs1436225984 997 dbSNP
rs969803780 1000 dbSNP
rs1016361649 1001 dbSNP
rs1329060313 1010 dbSNP
rs1410893248 1013 dbSNP
rs984433128 1014 dbSNP
rs953083470 1016 dbSNP
rs1162047906 1022 dbSNP
rs1459181188 1023 dbSNP
rs192396289 1024 dbSNP
rs959875393 1027 dbSNP
rs1025891986 1029 dbSNP
rs1437867278 1029 dbSNP
rs1205411228 1030 dbSNP
rs1163389669 1032 dbSNP
rs561718617 1046 dbSNP
rs201631390 1050 dbSNP
rs144682204 1052 dbSNP
rs1209224694 1064 dbSNP
rs370956160 1066 dbSNP
rs901320497 1068 dbSNP
rs540330989 1069 dbSNP
rs1016585808 1070 dbSNP
rs753288686 1072 dbSNP
rs1279774630 1075 dbSNP
rs984114964 1075 dbSNP
rs1391895604 1087 dbSNP
rs1443916740 1088 dbSNP
rs1321959950 1097 dbSNP
rs760381313 1097 dbSNP
rs573215265 1098 dbSNP
rs1043460067 1099 dbSNP
rs1246009377 1102 dbSNP
rs1165972356 1111 dbSNP
rs754785832 1112 dbSNP
rs1184997963 1114 dbSNP
rs947402713 1116 dbSNP
rs891754450 1118 dbSNP
rs1007462695 1119 dbSNP
rs1266278009 1119 dbSNP
rs371917216 1119 dbSNP
rs890072570 1127 dbSNP
rs1052948751 1134 dbSNP
rs938547424 1144 dbSNP
rs150503011 1148 dbSNP
rs928484021 1149 dbSNP
rs947056075 1149 dbSNP
rs1277368469 1150 dbSNP
rs891440229 1150 dbSNP
rs1052864398 1151 dbSNP
rs1229837927 1151 dbSNP
rs938370878 1152 dbSNP
rs1364915141 1154 dbSNP
rs928369792 1161 dbSNP
rs979991181 1163 dbSNP
rs1346486208 1165 dbSNP
rs1367784110 1168 dbSNP
rs979935875 1169 dbSNP
rs140007416 1170 dbSNP
rs543613651 1170 dbSNP
rs780116290 1170 dbSNP
rs556477279 1173 dbSNP
rs1423362792 1174 dbSNP
rs756634084 1176 dbSNP
rs1025562502 1180 dbSNP
rs908927501 1191 dbSNP
rs1429105717 1196 dbSNP
rs1191490026 1204 dbSNP
rs1485488957 1204 dbSNP
rs538434107 1211 dbSNP
rs984896325 1228 dbSNP
rs1217347373 1231 dbSNP
rs1309879722 1232 dbSNP
rs1177897114 1237 dbSNP
rs1223679311 1238 dbSNP
rs972706473 1245 dbSNP
rs950409934 1247 dbSNP
rs965525781 1249 dbSNP
rs1361834406 1263 dbSNP
rs1190854377 1277 dbSNP
rs761164400 1278 dbSNP
rs1433007054 1279 dbSNP
rs1357433335 1282 dbSNP
rs1020103885 1284 dbSNP
rs1470417286 1295 dbSNP
rs1431224861 1300 dbSNP
rs577903798 1307 dbSNP
rs753248901 1308 dbSNP
rs1168230896 1317 dbSNP
rs768010232 1319 dbSNP
rs1420164333 1325 dbSNP
rs1007084605 1330 dbSNP
rs1206480087 1331 dbSNP
rs759954533 1337 dbSNP
rs1203973311 1344 dbSNP
rs1021900347 1347 dbSNP
rs1250129909 1348 dbSNP
rs1462362952 1352 dbSNP
rs556514271 1355 dbSNP
rs1217220132 1356 dbSNP
rs1313172466 1358 dbSNP
rs1007027077 1359 dbSNP
rs1052807839 1360 dbSNP
rs751897801 1362 dbSNP
rs954305142 1366 dbSNP
rs1021709914 1367 dbSNP
rs576319585 1369 dbSNP
rs1394165305 1370 dbSNP
rs891784239 1372 dbSNP
rs1053020065 1373 dbSNP
rs1002763362 1375 dbSNP
rs1304548214 1380 dbSNP
rs1028668447 1383 dbSNP
rs557869495 1391 dbSNP
rs1445880008 1392 dbSNP
rs1236006723 1394 dbSNP
rs1194818675 1396 dbSNP
rs948599148 1397 dbSNP
rs1479612444 1398 dbSNP
rs907088598 1400 dbSNP
rs374837720 1401 dbSNP
rs1044627081 1402 dbSNP
rs948571362 1403 dbSNP
rs929265596 1404 dbSNP
rs1202752813 1405 dbSNP
rs187828318 1415 dbSNP
rs14271 1416 dbSNP
rs1373865950 1420 dbSNP
rs1299650796 1422 dbSNP
rs1456369585 1423 dbSNP
rs1364918538 1425 dbSNP
rs1164079181 1431 dbSNP
rs1426019295 1431 dbSNP
rs965740041 1432 dbSNP
rs1180718505 1433 dbSNP
rs1419278963 1433 dbSNP
rs1330704443 1437 dbSNP
rs772400148 1437 dbSNP
rs912668770 1438 dbSNP
rs928981885 1448 dbSNP
rs1489947155 1449 dbSNP
rs918946890 1453 dbSNP
rs139670015 1454 dbSNP
rs41280772 1455 dbSNP
rs146095672 1457 dbSNP
rs956307585 1458 dbSNP
rs1336549119 1461 dbSNP
rs1314746948 1466 dbSNP
rs1402897076 1467 dbSNP
rs1344573025 1471 dbSNP
rs1303694703 1480 dbSNP
rs912811973 1481 dbSNP
rs1358129720 1484 dbSNP
rs1044164107 1485 dbSNP
rs142831718 1485 dbSNP
rs529632901 1485 dbSNP
rs1401215583 1486 dbSNP
rs1479661531 1487 dbSNP
rs76391189 1488 dbSNP
rs1200856203 1489 dbSNP
rs775634541 1490 dbSNP
rs1048917590 1491 dbSNP
rs184417664 1495 dbSNP
rs1022156678 1496 dbSNP
rs1469669161 1497 dbSNP
rs1221843578 1499 dbSNP
rs1362179412 1505 dbSNP
rs1322618492 1507 dbSNP
rs919199747 1511 dbSNP
rs1225315132 1512 dbSNP
rs1324649428 1512 dbSNP
rs1190221205 1515 dbSNP
rs1424962450 1520 dbSNP
rs1317490221 1526 dbSNP
rs1011675348 1528 dbSNP
rs1382310495 1530 dbSNP
rs772119200 1533 dbSNP
rs956101145 1534 dbSNP
rs1040674574 1539 dbSNP
rs1468958791 1543 dbSNP
rs1429091457 1546 dbSNP
rs561755558 1556 dbSNP
rs1481602153 1557 dbSNP
rs1466554165 1567 dbSNP
rs1371874330 1569 dbSNP
rs944068442 1571 dbSNP
rs912521239 1572 dbSNP
rs985565907 1572 dbSNP
rs745663402 1573 dbSNP
rs1225138941 1580 dbSNP
rs1263944265 1580 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ugCGUCUCGGGCUUUCGGGGGuca 5'
            || |:|:||     |||:|   
Target 5' ccGCCGGGUCC----UCCCUC--- 3'
3 - 19
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions C8166
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3 ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5 PAR-CLIP data was present in ERX177602. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_4 PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11 PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1 PAR-CLIP data was present in ERX177614. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_4 PAR-CLIP data was present in ERX177617. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_7 PAR-CLIP data was present in ERX177621. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_11 PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1 PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6 PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11 PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5 PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7 PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8 PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5 PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
CLIP-seq Support 1 for dataset GSM4903833
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_a
Location of target site NM_014944 | 3UTR | CUCCCCCAGGAGCCC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM4903837
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_b
Location of target site NM_014944 | 3UTR | CUCCCCCAGGAGCCC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM545212
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / Control
Location of target site ENST00000377298.4 | 3UTR | UCCCGCCGGGUCCUCCCUC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM545214
Method / RBP PAR-CLIP / AGO3
Cell line / Condition HEK293 / Control
Location of target site ENST00000377298.4 | 3UTR | UCCCGCCGGGUCCUCCCUC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset GSM1462572
Method / RBP PAR-CLIP / AGO2
Cell line / Condition C8166 / C8166 NL4-3
Location of target site ENST00000377298.4 | 3UTR | CGGGCUCUUCCCGCCGGGUCCUCCCUCCC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE28544 Breast cancer 0.627 5.2e-4 0.585 1.3e-3 24 Click to see details
GSE28260 Renal cortex and medulla 0.615 1.3e-2 0.648 8.3e-3 13 Click to see details
GSE42095 Differentiated embryonic stem cells -0.426 2.1e-2 -0.422 2.2e-2 23 Click to see details
GSE17306 Multiple myeloma 0.213 7.1e-2 0.469 3.4e-4 49 Click to see details
GSE38226 Liver fibrosis -0.303 9.1e-2 -0.274 1.1e-1 21 Click to see details
GSE21687 Ependynoma primary tumors 0.169 9.1e-2 0.096 2.3e-1 64 Click to see details
GSE26953 Aortic valvular endothelial cells -0.266 1.0e-1 -0.067 3.8e-1 24 Click to see details
GSE17498 Multiple myeloma 0.182 1.3e-1 0.239 6.9e-2 40 Click to see details
GSE32688 Pancreatic cancer 0.126 2.5e-1 0.177 1.7e-1 32 Click to see details
GSE14794 Lymphoblastoid cells -0.073 2.5e-1 -0.046 3.3e-1 90 Click to see details
GSE38974 Chronic obstructive pulmonary disease 0.089 3.4e-1 0.103 3.1e-1 25 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis 0.067 3.9e-1 0.505 1.2e-2 20 Click to see details
GSE27834 Pluripotent stem cells 0.024 4.6e-1 0.153 2.9e-1 16 Click to see details
GSE21849 B cell lymphoma 0.009 4.8e-1 0.126 2.6e-1 29 Click to see details
GSE21849 B cell lymphoma 0.009 4.8e-1 0.126 2.6e-1 29 Click to see details
GSE21849 B cell lymphoma 0.009 4.8e-1 0.126 2.6e-1 29 Click to see details
GSE21849 B cell lymphoma 0.009 4.8e-1 0.126 2.6e-1 29 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
69 hsa-miR-637 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT006147 SP7 Sp7 transcription factor 3 1
MIRT054906 COL4A1 collagen type IV alpha 1 chain 1 1
MIRT159142 NRBP1 nuclear receptor binding protein 1 2 2
MIRT358526 HNRNPAB heterogeneous nuclear ribonucleoprotein A/B 2 2
MIRT441490 NCEH1 neutral cholesterol ester hydrolase 1 2 2
MIRT443472 ACPP acid phosphatase, prostate 2 2
MIRT464631 UBE4A ubiquitination factor E4A 2 2
MIRT465259 TRIM44 tripartite motif containing 44 2 2
MIRT473975 LRRC58 leucine rich repeat containing 58 2 2
MIRT475168 IP6K1 inositol hexakisphosphate kinase 1 2 2
MIRT477631 EFNA1 ephrin A1 2 2
MIRT480100 CALR calreticulin 2 2
MIRT483504 STMN3 stathmin 3 2 4
MIRT483735 THSD4 thrombospondin type 1 domain containing 4 2 2
MIRT483847 UNC5B unc-5 netrin receptor B 2 2
MIRT485973 RTBDN retbindin 2 2
MIRT486616 METTL6 methyltransferase like 6 2 2
MIRT487847 CLSTN1 calsyntenin 1 2 4
MIRT488675 WWP2 WW domain containing E3 ubiquitin protein ligase 2 2 4
MIRT489046 PRPF4B pre-mRNA processing factor 4B 2 2
MIRT490612 SLC47A1 solute carrier family 47 member 1 2 4
MIRT490990 USP22 ubiquitin specific peptidase 22 2 2
MIRT492559 PRX periaxin 2 2
MIRT494667 ARL8A ADP ribosylation factor like GTPase 8A 2 2
MIRT495880 DPY19L1 dpy-19 like C-mannosyltransferase 1 2 2
MIRT496778 ADAMTS14 ADAM metallopeptidase with thrombospondin type 1 motif 14 2 2
MIRT499742 USH1G USH1 protein network component sans 2 4
MIRT500371 ZNF385A zinc finger protein 385A 2 2
MIRT503257 KIF18B kinesin family member 18B 2 2
MIRT504511 PPP1R9B protein phosphatase 1 regulatory subunit 9B 2 2
MIRT511940 FAM127B retrotransposon Gag like 8A 2 2
MIRT514606 NDUFA12 NADH:ubiquinone oxidoreductase subunit A12 2 4
MIRT527187 CLASP1 cytoplasmic linker associated protein 1 2 2
MIRT532494 HOXA13 homeobox A13 2 2
MIRT533504 TRIM71 tripartite motif containing 71 2 2
MIRT539171 AR androgen receptor 2 2
MIRT542735 RBFOX2 RNA binding protein, fox-1 homolog 2 2 2
MIRT544647 PHF8 PHD finger protein 8 2 4
MIRT546232 TNRC18P2 trinucleotide repeat containing 18 pseudogene 2 2 2
MIRT548372 ENTPD5 ectonucleoside triphosphate diphosphohydrolase 5 2 4
MIRT555913 ORMDL3 ORMDL sphingolipid biosynthesis regulator 3 2 2
MIRT565381 TGOLN2 trans-golgi network protein 2 2 2
MIRT568954 RUNX3 runt related transcription factor 3 2 2
MIRT570205 RAP1GAP2 RAP1 GTPase activating protein 2 2 2
MIRT573599 CERS1 ceramide synthase 1 2 2
MIRT615364 CCNF cyclin F 2 2
MIRT616102 HOXB5 homeobox B5 2 2
MIRT619127 CD40LG CD40 ligand 2 2
MIRT634968 C8orf17 chromosome 8 open reading frame 17 2 2
MIRT646665 FNBP1 formin binding protein 1 2 2
MIRT649633 RASA4 RAS p21 protein activator 4 2 2
MIRT658443 FAM167B family with sequence similarity 167 member B 2 2
MIRT660237 BMP7 bone morphogenetic protein 7 2 2
MIRT669467 ATL3 atlastin GTPase 3 2 2
MIRT670557 SHISA2 shisa family member 2 2 2
MIRT671035 PCDHB2 protocadherin beta 2 2 2
MIRT684255 TBXA2R thromboxane A2 receptor 2 2
MIRT688619 CYBRD1 cytochrome b reductase 1 3 2
MIRT694346 CHST6 carbohydrate sulfotransferase 6 2 2
MIRT695516 ALPI alkaline phosphatase, intestinal 2 2
MIRT697512 ZBTB7A zinc finger and BTB domain containing 7A 2 2
MIRT700133 RNF144B ring finger protein 144B 2 2
MIRT711667 TRMT5 tRNA methyltransferase 5 2 2
MIRT712156 TAOK1 TAO kinase 1 2 2
MIRT712463 KCNC3 potassium voltage-gated channel subfamily C member 3 2 2
MIRT720759 FAM193A family with sequence similarity 193 member A 2 2
MIRT731198 AKT1 AKT serine/threonine kinase 1 2 1
MIRT755463 PACS2 phosphofurin acidic cluster sorting protein 2 1 1
MIRT755522 FOXM1 forkhead box M1 3 1
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-637 Sorafenib 216239 NSC747971 approved sensitive High Hepatocellular Carcinoma tissue
hsa-miR-637 Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-637 Cisplatin 5460033 NSC119875 approved sensitive Low Squamous Cell Carcinoma cell line (SCC-11)
hsa-miR-637 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-637 Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-637 Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (WM266) (50nM)
hsa-miR-637 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (WM266) (50nM)
hsa-miR-637 Tivantinib 11494412 NSC758242 resistant High Breast Cancer cell line (BT-20, BT-474, BT-549, CAMA-1, HCC1143, HCC1395, HCC1569, HCC1806, HCC-1937, HCC1954, HCC202, HCC38, HCC70, Hs578T, MCF-7, MDA-MB-175VII, MDA-MB-231, MDA-MB-361, MDA-MB-415, MDA-MB-436, MDA-MB-468, SKBR3, T47D, UACC812, EVSA-T, MPE-600 , SK-BR-
hsa-miR-637 Oxaliplatin 6857599 NSC266046 approved sensitive Low Colorectal Cancer cell line (HT-29, HCT-116)
hsa-miR-637 Sevoflurane 5206 NSC760367 approved sensitive Low Colorectal Cancer cell line
hsa-mir-637 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-637 Paclitaxel 36314 NSC125973 approved resistant cell line (A2780)
hsa-mir-637 Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-mir-637 Androstenedione+Anastrozole sensitive cell line (MCF-7)
hsa-mir-637 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-miR-637 Temozolomide 5394 NSC362856 approved sensitive cell line (U251)
hsa-miR-637 Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-637 Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-637 Pegylated interferon alpha+Ribavirin sensitive tissue (chronic hepatitis C)
hsa-miR-637 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-637 Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-637 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-637 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)

Error report submission